Pretax income is the income that a company earns before paying income taxes. Dermapharm Holding SE's pretax income for the
three
months ended in Dec. 2024 was €35 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was €172 Mil.
Dermapharm Holding SE's pretax margin was 11.89%.
During the past 12 years, Dermapharm Holding SE's highest Pretax Margin was 31.07%. The lowest was 9.34%. And the median was 17.00%.
Dermapharm Holding SE Pre-Tax Income Historical Data
The historical data trend for Dermapharm Holding SE's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Dermapharm Holding SE's Pre-Tax Income
For the Drug Manufacturers - Specialty & Generic subindustry, Dermapharm Holding SE's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dermapharm Holding SE's Pre-Tax Income Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dermapharm Holding SE's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Dermapharm Holding SE's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €172 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dermapharm Holding SE (LTS:0A5J) Pre-Tax Income Explanation
Dermapharm Holding SE's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as
During the past 12 years, Dermapharm Holding SE's highest Pretax Margin was 31.07%. The lowest was 9.34%. And the median was 17.00%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dermapharm Holding SE Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Dermapharm Holding SE's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals and other healthcare products which drive key revenue, Herbal extracts, and Parallel import business. Branded pharmaceuticals and other healthcare products focus on the development, manufacturing, and marketing of branded pharmaceuticals and other healthcare products. Herbal extracts include the manufacturing of phytopharmaceuticals, nutraceuticals, and cosmetics products. Parallel import brands business operates under the AxiCorp brand.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LTS:0A5J has been successfully added to your 